Supplementary Figure 2 from PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients

Autor: Richard A. Scolyer, Georgina V. Long, Peter Hersey, Richard F. Kefford, John F. Thompson, Jennifer H. Yearley, Lauren E. Haydu, Ricardo Vilain, Alexander M. Menzies, James S. Wilmott, Hojabr Kakavand
Rok vydání: 2023
DOI: 10.1158/1078-0432.22458545
Popis: Supplementary Figure 2. LAG3 and FoxP3 expressing lymphocytes at PRE, EDT and PROG. Patients treated with either BRAFi (A-B) or Combi (C-D) showed no significant changes in LAG3+ and FoxP3+ lymphocytes at any time point.
Databáze: OpenAIRE